258 related articles for article (PubMed ID: 33609753)
1. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
Bessone F; Hernandez N; Tagle M; Arrese M; Parana R; Méndez-Sánchez N; Ridruejo E; Mendizabal M; Dagher L; Contreras F; Fassio E; Pessoa M; Brahm J; Silva M
Ann Hepatol; 2021; 24():100321. PubMed ID: 33609753
[TBL] [Abstract][Full Text] [Related]
2. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
Bessone F; Hernandez N; Lucena MI; Andrade RJ;
Int J Mol Sci; 2016 Feb; 17(3):313. PubMed ID: 26938524
[TBL] [Abstract][Full Text] [Related]
3. Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network.
Bessone F; García-Cortés M; Medina-Caliz I; Hernandez N; Parana R; Mendizabal M; Schinoni MI; Ridruejo E; Nunes V; Peralta M; Santos G; Anders M; Chiodi D; Tagle M; Montes P; Carrera E; Arrese M; Lizarzabal MI; Alvarez-Alvarez I; Caballano-Infantes E; Niu H; Pinazo J; Cabello MR; Lucena MI; Andrade RJ
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e548-e563. PubMed ID: 33434654
[TBL] [Abstract][Full Text] [Related]
4. Overview on drug-induced liver injury in Brazil.
Bessone F
World J Gastrointest Pharmacol Ther; 2021 Sep; 12(5):100-102. PubMed ID: 34616586
[TBL] [Abstract][Full Text] [Related]
5. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.
Ortega-Alonso A; Stephens C; Lucena MI; Andrade RJ
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187363
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of idiosyncratic drug-induced liver injury.
Hassan A; Fontana RJ
Liver Int; 2019 Jan; 39(1):31-41. PubMed ID: 30003672
[TBL] [Abstract][Full Text] [Related]
8. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports.
Hernández N; Bessone F; Sánchez A; di Pace M; Brahm J; Zapata R; A Chirino R; Dávalos M; Méndez-Sánchez N; Arrese M; Schinoni M; Lucena MI; Andrade RJ
Ann Hepatol; 2014; 13(2):231-9. PubMed ID: 24552865
[TBL] [Abstract][Full Text] [Related]
9. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
10. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
[TBL] [Abstract][Full Text] [Related]
11. Drug induced liver injury: an update.
Garcia-Cortes M; Robles-Diaz M; Stephens C; Ortega-Alonso A; Lucena MI; Andrade RJ
Arch Toxicol; 2020 Oct; 94(10):3381-3407. PubMed ID: 32852569
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
[TBL] [Abstract][Full Text] [Related]
13. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
14. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
Chalasani NP; Maddur H; Russo MW; Wong RJ; Reddy KR;
Am J Gastroenterol; 2021 May; 116(5):878-898. PubMed ID: 33929376
[TBL] [Abstract][Full Text] [Related]
15. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.
Treem WR; Palmer M; Lonjon-Domanec I; Seekins D; Dimick-Santos L; Avigan MI; Marcinak JF; Dash A; Regev A; Maller E; Patwardhan M; Lewis JH; Rockey DC; Di Bisceglie AM; Freston JW; Andrade RJ; Chalasani N
Drug Saf; 2021 Feb; 44(2):133-165. PubMed ID: 33141341
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
Fontana RJ
Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions and organ damage: The liver.
Licata A
Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK; Björnsson ES
Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
[TBL] [Abstract][Full Text] [Related]
20. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.
Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW
Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
